Cofepris authorizes health registration for reusable insulin pen
Cofepris authorizes health registration for reusable insulin pen
The approval of the reusable GO-PEN in Mexico marks a significant advance in access to medical technologies for diabetes management. This device enables the use of vial insulin with precise dosing, offering a sustainable alternative to conventional disposable injections. This innovation is crucial because it democratizes access to safer, reusable devices—a fundamental principle in opening up healthcare solutions. By reducing dependence on single-use products, it promotes a more efficient and accessible healthcare model for patients with chronic conditions. The relevance to open data lies in the need to transparently assess the real impact of these technologies on public health. Generating and sharing data on their adoption, costs, and clinical outcomes allows for the evaluation of their effectiveness and the guidance of evidence-based health policies, fostering accountability in the management of healthcare resources.
Source: excelsior.com.mxPublished on 2026-11-05
Related news
- Unemployment rises by 2,059 in October in Castilla-La Mancha, reaching 120,192 jobless
- Brazil records record aquaculture production in public waters - Prensa Latina News
- Privacy Policy - Jornada
- The EU sold wind turbines worth €3.1 billion in 2025, but the story flips for solar panels: almost all are sourced from China
- The Government approves the AI Ethics Code to ensure a fairer and more transparent digital state | Uncompromising Truth